Isolation of circulating cancer cells from whole blood by immunomagnetic cell enrichment and unenriched immunocytochemistry in vitro

Journal of Urology

Volumn 169, Issue 2, 2003, Pages 701-705

  Zigeuner, Richard E ^a   Riesenberg, Rainer ^a   Pohla, Heike ^a   Hofstetter, Alfons ^a   Oberneder, Ralph ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Immunocytochemistry; Immunomagnetic enrichment; Magnetic beads; Micrometastases; Tumor cell dissemination

Indexed keywords

CD45 ANTIGEN; CYTOKERATIN; LEUKOCYTE ANTIBODY;

ARTICLE; BLOOD; CANCER CELL; CELL ISOLATION; CELL SEPARATION; CELL SUSPENSION; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOMAGNETIC SEPARATION; INTERMETHOD COMPARISON; MONONUCLEAR CELL; NORMAL HUMAN; PRIORITY JOURNAL; TUMOR CELL; URINARY TRACT CANCER;

EID: 0037306101     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)63996-1     Document Type: Article

References (22)

1. Pantel, K., Izbicki, J., Passlick, B., Angstwurm, M., Haussinger, K., Thetter, O. et al: Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with nonsmall-cell lung cancer without overt metastases. Lancet, 347: 649, 1996
2. Zigeuner, R., Riesenberg, R., Pohla, H., Hofstetter A. and Oberneder, R.: Immunomagnetic cell enrichment detects more disseminated cancer cells than immunocytochemistry in vitro. J Urol, 164: 1834, 2000
3. Pretlow, T. G., Schwartz, S., Giaconia, J. M., Wright, A. L., Grimm, H. A., Edgehouse, N. L. et al: Prostate cancer and other xenografts from cells in peripheral blood of patients. Cancer Res, 60: 4033, 2000
4. Stone, K. R., Mickey, D. D., Wunderli, H., Mickey, G. H. and Paulson, D. F.: Isolation of a human prostate carcinoma cell line (DU 145). Int J Cancer, 21: 274, 1978
5. Rigby, C. C. and Franks, L. M.: A human tissue culture cell line from a transitional cell tumour of the urinary bladder: Growth, chromosome pattern and ultrastructure. Br J Cancer, 24: 746, 1970
6. Loos, J. A. and Roos, D.: Ficoll-isopaque gradients for the determination of density distributions of human blood lymphocytes and other reticulo-endothelial cells. Exp Cell Res, 86: 333, 1974
7. Martin, V. M., Siewert, C., Scharl, A., Harms, T., Heinze, R., Oehl, S. et al: Immunomagnetic enrichment of disseminated epithelial tumor cells from peripheral blood by MACS. Exp Hematol, 26: 252, 1998
8. Haukanes, B. I. and Kvam, C.: Application of magnetic beads in bioassays. Biotechnology, 11: 60, 1993
9. Hardingham, J. E., Kotasek, D., Farmer, B., Butler, R. N., Mi, J. X., Sage, R. E. et al: Immunobead-PCR: A technique for the detection of circulating tumor cells using immunomagnetic beads and the polymerase chain reaction. Cancer Res, 53: 3455, 1993
10. Rye, P. D., Hoifodt, H. K., Overli, G. E. and Fodstad, O.: Immunobead filtration: A novel approach for the isolation and propagation of tumor cells. Am J Pathol, 150: 99, 1997
11. Griwatz, C., Brandt, B., Assmann, G. and Zanker, K. S.: An immunological enrichment method for epithelial cells from peripheral blood. J Immunol Methods, 183: 251, 1995
12. Kielhorn, E., Schofield, K. and Rimm, D. L.: Use of magnetic enrichment for detection of carcinoma cells in fluid specimens. Cancer, 94: 205, 2002
13. Kruger, W., Datta, C., Badbaran, A., Togel, F., Gutensohn, K., Carrero, I. et al: Immunomagnetic tumor cell selection implications for the detection of disseminated cancer cells. Transfusion, 40: 1489, 2000
14. Makarovskiy, A. N., Ackerley, W., Wojcik, L., 3rd, Halpert, G. K., Stein, B. S., Carreiro, M. P. et al: Application of immunomagnetic beads in combination with RT-PCR for the detection of circulating prostate cancer cells. J Clin Lab Anal, 11: 346, 1997
15. Bilkenroth, U., Taubert, H., Riemann, D., Rebmann, U., Heynemann, H. and Meye, A.: Detection and enrichment of disseminated renal carcinoma cells from peripheral blood by immunomagnetic cell separation. Int J Cancer, 92: 577, 2001
16. Fadlon, E. J., Rees, R. C., McIntyre, C., Sharrard, R. M., Lawry, J. and Hamdy, F. C.: Detection of circulating prostate-specific antigen-positive cells in patients with prostate cancer by flow cytometry and reverse transcription polymerase chain reaction. Br J Cancer, 74: 400, 1996
17. Ellis, W. J., Vessella, R. L., Corey, E., Arfman, E. W., Oswin, M. M., Melchior, S. et al: The value of a reverse transcriptase polymerase chain reaction assay in preoperative staging and follow up of patients with prostate cancer. J Urol, 159: 1134, 1998
18. Ignatoff, J. M., Oefelein, M. G., Watkin, W., Chmiel, J. S. and Kaul, K. L.: Prostate specific antigen reverse transcriptase-polymerase chain reaction assay in preoperative staging of prostate cancer. J Urol, 158: 1870, 1997
19. Thiounn, N., Saporta, F., Flam, T. A., Pages, F., Zerbib, M., Viellefond, A. et al: Positive prostate-specific antigen circulating cells detected by reverse transcriptase-polymerase chain reaction does not imply the presence of prostatic micrometastases. Urology, 50: 245, 1997
20. Hussain, M., Kukuruga, M., Biggar, S., Sakr, W., Cummings, G. and Ensley, J.: Prostate cancer: Flow cytometric methods for detection of bone marrow micrometastases. Cytometry, 26: 40, 1996
21. Leonard, R. C., Duncan, L. W. and Hay, F. G.: Immunocytological detection of residual marrow disease at clinical remission predicts metastatic relapse in small cell lung cancer. Cancer Res, 50: 6545, 1990
22. O'Sullivan, G. C., Collins, J. K., Kelly, J., Morgan, J., Madden, M. and Shanahan, F.: Micrometastases: Marker of metastatic potential or evidence of residual disease? Gut, 40: 512, 1997